A cGMP PDE inhibitor and metabolite of theophylline and caffeine
Technical Support & Resources

Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

3-Methylxanthine

Item No. 34288

Technical Information
Formal Name
3,9-dihydro-3-methyl-1H-purine-2,6-dione
CAS Number
1076-22-8
Synonyms
  • 3-MTX
  • 3-MX
  • NSC 515466
Molecular Formula
C6H6N4O2
Formula Weight
Purity
≥98%
A solid
λmax
272 nm
SMILES
O=C1NC(N(C)C2=C1NC=N2)=O
InChi Code
InChI=1S/C6H6N4O2/c1-10-4-3(7-2-8-4)5(11)9-6(10)12/h2H,1H3,(H,7,8)(H,9,11,12)
InChi Key
GMSNIKWWOQHZGF-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Cayman Chemical
    Visit Our Cancer Resource Center
    Find Tools & Resources to Study the Hallmarks of Cancer
    • Cancer cell signaling & regulation
    • Cancer metabolism
    • Tumor microenvironment
    EXPLORE NOW
    Product Description

    3-Methylxanthine is a cGMP phosphodiesterase (PDE) inhibitor and a metabolite of theophylline (Item No. 23760) and caffeine (Item No. 14118).1,2,3 It is formed from theophylline by the cytochrome P450 (CYP) isoform CYP1A2 and from caffeine via 6A5NF-1,3-dimethyluracil, 1,3,7-trimethyluric acid, or theobromine intermediates. 3-Methylxanthine inhibits cGMP PDE in isolated guinea pig trachealis muscle with an IC50 value of 920 µM.1 It is neurotoxic to mice, inducing convulsions with an ED50 value of 1,107 nmol/kg.4

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Tanaka, H., Ogawa, K., Takagi, K., et alInhibition of cyclic GMP phosphodiesterase by xanthine derivatives relaxes guinea-pig trachealis smooth muscle. Clin. Exp. Pharmacol. Physiol. 18(3), 163-168 (1991).

    2. Camandola, S., Plick, N., and Mattson, M.P. Impact of coffee and cacao purine metabolites on neuroplasticity and neurodegenerative disease. Neurochem. Res. 44(1), 214-227 (2019).

    3. Ha, H.R., Chen, J., Freiburghaus, A.U., et alMetabolism of theophylline by cDNA-expressed human cytochromes P-450. Br. J. Clin. Pharmacol. 39(3), 321-326 (1995).

    4. Yamamoto, K., Toyama, E., Kawakami, J., et alNeurotoxic convulsions induced by theophylline and its metabolites in mice. Biol. Pharm. Bull. 19(6), 869-872 (1996).